BlackRock’s Palisade Bio PALI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $3.28M | Sell |
1,876,340
-2,979
| -0.2% | -$5.42K | ﹤0.01% | 3987 |
|
|
2025
Q4 | $4.42M | Buy |
+1,879,319
| New | +$3.61M | ﹤0.01% | 3882 |
|
|
2024
Q2 | – | Sell |
-1
| Closed | -$4 | – | 5337 |
|
|
2024
Q1 | $4 | Hold |
1
| – | – | ﹤0.01% | 5278 |
|
|
2023
Q4 | $5 | Hold |
1
| – | – | ﹤0.01% | 5365 |
|
|
2023
Q3 | $5 | Hold |
1
| – | – | ﹤0.01% | 5438 |
|
|
2023
Q2 | $15 | Hold |
1
| – | – | ﹤0.01% | 5484 |
|
|
2023
Q1 | $28 | Hold |
1
| – | – | ﹤0.01% | 5551 |
|
|
2022
Q4 | $42 | Hold |
1
| – | – | ﹤0.01% | 5739 |
|
|
2022
Q3 | $0 | Hold |
1
| – | – | ﹤0.01% | 5896 |
|
|
2022
Q2 | $0 | Sell |
1
-28
| -97% | -$13.5K | ﹤0.01% | 5949 |
|
|
2022
Q1 | $22K | Sell |
29
-1
| -3% | -$808 | ﹤0.01% | 5557 |
|
|
2021
Q4 | $29K | Sell |
30
-8
| -21% | -$14K | ﹤0.01% | 5504 |
|
|
2021
Q3 | $76K | Buy |
38
+5
| +15% | +$11K | ﹤0.01% | 5207 |
|
|
2021
Q2 | $101K | Buy |
33
+32
| +3,200% | +$145K | ﹤0.01% | 5046 |
|
|
2021
Q1 | $6K | Hold |
1
| – | – | ﹤0.01% | 5124 |
|
|
2020
Q4 | $3K | Hold |
1
| – | – | ﹤0.01% | 4959 |
|
|
2020
Q3 | $2K | Hold |
1
| – | – | ﹤0.01% | 4946 |
|
|
2020
Q2 | $2K | Hold |
1
| – | – | ﹤0.01% | 4912 |
|
|
2020
Q1 | $2K | Hold |
1
| – | – | ﹤0.01% | 4854 |
|
|
2019
Q4 | $3K | Hold |
1
| – | – | ﹤0.01% | 4845 |
|
|
2019
Q3 | $6K | Hold |
1
| – | – | ﹤0.01% | 4770 |
|
|
2019
Q2 | $21K | Hold |
1
| – | – | ﹤0.01% | 4678 |
|
|
2019
Q1 | $31K | Hold |
1
| – | – | ﹤0.01% | 4542 |
|
|
2018
Q4 | $22K | Hold |
1
| – | – | ﹤0.01% | 4570 |
|
|
2018
Q3 | $75K | Hold |
1
| – | – | ﹤0.01% | 4496 |
|
|
2018
Q2 | $78K | Hold |
1
| – | – | ﹤0.01% | 4498 |
|
|
2018
Q1 | $162K | Hold |
1
| – | – | ﹤0.01% | 4250 |
|
|
2017
Q4 | $170K | Hold |
1
| – | – | ﹤0.01% | 4241 |
|
|
2017
Q3 | $129K | Hold |
1
| – | – | ﹤0.01% | 4323 |
|
|
2017
Q2 | $545K | Hold |
1
| – | – | ﹤0.01% | 4002 |
|
|
2017
Q1 | $410K | Buy |
+1
| New | +$381K | ﹤0.01% | 4018 |
|
|
2015
Q2 | – | Hold |
0
| – | -$3K | – | 3258 |
|
|
2015
Q1 | – | Hold |
0
| – | – | – | 3098 |
|
|
2014
Q4 | – | Hold |
0
| – | – | – | 3065 |
|
|
2014
Q3 | – | Hold |
0
| – | – | – | 3009 |
|
|
2014
Q2 | – | Hold |
0
| – | – | – | 3005 |
|
|
2014
Q1 | – | Hold |
0
| – | – | – | 3158 |
|
Other funds holding PALI
BGI
OCA
PA
CC
RCM
EP
BlackRock's PALI Position: Q1 2026 in Review
BlackRock reduced its Palisade Bio (PALI) stake by 0.16% in Q1 2026, selling an estimated $5.42K and leaving 1,876,340 shares worth $3.28M. The position accounts for ﹤0.01% of the portfolio, ranked #3987.
BlackRock first reported a position in PALI in Q1 2017 and has held it in 31 quarters since. The position peaked at $4.42M in Q4 2025. 96 funds tracked by Wall St. Rank hold PALI as of Q1 2026.
- BlackRock held 1,876,340 shares of Palisade Bio worth $3.28M as of Q1 2026.
- BlackRock sold 2,979 Palisade Bio shares in Q1 2026, an estimated $5.42K.
- Palisade Bio made up ﹤0.01% of BlackRock's portfolio in Q1 2026, its #3987 holding.
- BlackRock first reported a position in Palisade Bio in Q1 2017 and has held it in 31 quarters since.
- BlackRock's Palisade Bio position peaked at $4.42M in Q4 2025.
- 96 funds tracked by Wall St. Rank held Palisade Bio as of Q1 2026.
Based on BlackRock's 13F filing for Q1 2026, filed 13 May 2026.